Vimarsana
Biggest News Aggregation in the World

Page 6 - Expanded Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Access Today - Breaking & Trending Today

The Pearl Psychedelic Institute Announces $265,500 Grant from the Steven & Alexandra Cohen Foundation - Vimarsana News

The Pearl Psychedelic Institute Announces $265,500 Grant from the Steven & Alexandra Cohen Foundation

/PRNewswire/ -- The Pearl Psychedelic Institute ("The Pearl"), a 501c3 nonprofit organization which aims to bring psychedelic-assisted therapy into mainstream...

Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million - Vimarsana News

Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million ...

Tiziana Life Sciences Reports Positive 6-month Data With Intranasal Foralumab In Multiple Sclerosis - Vimarsana News

Tiziana Life Sciences Reports Positive 6-month Data With Intranasal Foralumab In Multiple Sclerosis

Tiziana Life Sciences Ltd. (TLSA), a clinical-stage biopharmaceutical company, announced Monday positive six-month clinical results in multiple sclerosis patients treated with intranasal Foralumab.

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab - Vimarsana News

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab

16.10.2023 - Numeric improvements were seen across key multiple sclerosis measures, including the Modified Fatigue Impact Scale, Expanded Disability Status Scale, Timed 25-Foot Walk test, Pyramidal Scores and NeuroQoL Fatigue scores.Data was presented at ECTRIMS ... Seite 1

Tiziana Life Sciences stock continues to climb; COO 'excited' by recent results - Vimarsana News

Tiziana Life Sciences stock continues to climb; COO 'excited' by recent results

Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares rose 8% to $0.86 in midday trading on Monday after the clinical-stage biopharmaceutical company revealed...